Investor Relations Investors Corporate Profile Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development and commercialization of life-changing therapies. Copyright West LLC. Minimum 15 minutes delayed. PRESS RELEASES 3/24/20 Alexion Statement on SOLIRIS® (eculizumab) and COVID-19 3/5/20 Alexion Announces Upcoming Data Presentations at 72nd Annual Meeting of the American Academy of Neurology SEE MORE EVENTS & PRESENTATIONS 03/03/20 at 9:20 AM EST Alexion to Present at 40th Annual Cowen Healthcare Conference Listen to Webcast 02/25/20 at 9:30 AM EST Alexion To Present at 9th Annual SVB Leerink Healthcare Conference Listen to Webcast SEE MORE